On May 7, 2022, Shanghai Municipal Science and Technology Commission announced the list of the second batch of technology-based smes to be warehoused in 2022. This time, a total of 3,921 technology-based smes were warehoused. Shanghai Pharmaceutical Tank successfully passed this year's identification and was successfully warehoused.

Shanghai is under lockdown due to COVID-19. Since the end of March 2022, all employees of our company in Shanghai have actively cooperated with the epidemic prevention work in Shanghai, staying indoors and working at home. During the lockdown period, due to the limited logistics, the daily necessities of the employees are increasingly short.

Recently, the Shanghai Municipal Science and Technology Commission, Shanghai Municipal Bureau of Finance and Shanghai Municipal Tax Bureau of the State Administration of Taxation jointly recognized that Shanghai Pharma was awarded the "High-tech Enterprise Certificate" of Shanghai.

Recently, the epidemic has occurred frequently in many places across the country, with Shanghai facing the most serious situation. Shanghai Pharmaceutical Pharmaceutical Research and Development Co., Ltd. is a R&D driven innovative drug research and development, production and service of high-tech enterprises, actively participate in the global research and production of anti-COVID-19 drugs and epidemic prevention and control products, actively contribute to Shanghai's frontline anti-epidemic cause.

In 2000, Lu Xianping, 38, joined the first batch of "technology returnees". The ambition is to make original medicines affordable to the Chinese people.

In recent years, due to the support of the national policy, the biomedical industry in our country is becoming the most active industry, and medical research and development can be described with each passing day. In view of the continuous updating of the regulatory policy of the FDA, more and more enterprises and personnel are engaged in pharmaceutical research and development.